Cagrilintide is a long-acting amylin analog being studied for weight management. It works differently from GLP-1 peptides by targeting the amylin pathway, which controls fullness and gastric emptying. Often researched alongside semaglutide for enhanced results.
Product Details
98%+ purity, third-party tested
Certificate of Analysis (COA) included
Fulfilled from the USA
For laboratory research use only (RUO) — not for human consumption